D Killander, A Dohlwitz, L Engstedt, S Franzén, G Gahrton, B Gullbring, G Holm, A Holmgren, S Höglund, A Killander, D Lockner, H Mellstedt, P J Moe, J Palmblad, P Reizenstein, K O Skårberg, B Swedberg, A M Udén, B Wadman, L Wide, L Ahström
One hundred and fourteen patients with acute leukemia, 57 children (10 AML and 47 ALL) and 57 adults (37 AML and 20 ALL) were treated with L-asparaginase (Asnase) 200 or 1000 IU/kg daily for 30 days unless withdrawn on account of side effects. Combinations with other cytotoxic drugs were used in all but eight patients. Hypersensitive reactions, decrease in Asnase activity in plasma, and bivalent antibodies to Asnase appeared more frequently in adults (28%, 46%, and 79%, respectively) than in children (16%, 17%, and 25% respectively)...
January 1976: Cancer